4/15/2026

Oxaliplatin Injection

Products Affected - Description

- Oxaliplatin injection, Accord, 5 mg/mL, 10 mL vial, 1 count, NDC 16729-0332-03
- Oxaliplatin injection, Accord, 5 mg/mL, 20 mL vial, 1 count, NDC 16729-0332-05
- Oxaliplatin injection, Fresenius Kabi, 5 mg/mL, 10 mL vial, 1 count, NDC 63323-0750-10
- Oxaliplatin injection, Ingenus Pharmaceuticals, 5 mg/mL, 10 mL vial, 1 count, NDC 50742-0405-10
- Oxaliplatin injection, Ingenus Pharmaceuticals, 5 mg/mL, 20 mL vial, 1 count, NDC 50742-0406-20
- Oxaliplatin injection, Pfizer, 5 mg/mL, 20 mL vial, 1 count, NDC 61703-0363-22
- Oxaliplatin injection, Sagent, 5 mg/mL, 10 mL vial, 1 count, NDC 25021-0233-10

Reason for the Shortage

- Accord did not provide a reason for the shortage.
- Apotex has oxaliplatin available.
- Fosun has oxaliplatin available.
- Fresenius Kabi did not provide a reason for the shortage.
- Ingenus did not provide a reason for the shortage.
- Meitheal has oxaliplatin available.
- Pfizer has oxaliplatin on shortage due to manufacturing delays.
- Sagent did not provide a reason for the shortage.
- Viatris has oxaliplatin available.

Available Products

- Oxaliplatin injection, Apotex, 5 mg/mL, 10 mL vial, 1 count, NDC 60505-6132-06
- Oxaliplatin injection, Apotex, 5 mg/mL, 20 mL vial, 1 count, NDC 60505-6132-07
- Oxaliplatin injection, Fosun Pharma, 5 mg/mL, 10 mL vial, 1 count, NDC 72266-0161-01
- Oxaliplatin injection, Fosun Pharma, 5 mg/mL, 20 mL vial, 1 count, NDC 72266-0162-01
- Oxaliplatin injection, Fresenius Kabi, 5 mg/mL, 20 mL vial, 1 count, NDC 63323-0750-20
- Oxaliplatin injection, Meitheal Pharmaceuticals, 5 mg/mL, 10 mL vial, 1 count, NDC 71288-0171-11
- Oxaliplatin injection, Meitheal Pharmaceuticals, 5 mg/mL, 20 mL vial, 1 count, NDC 71288-0172-21
- Oxaliplatin injection, Mylan (Viatris), 5 mg/mL, 10 mL vial, 1 count, NDC 67457-0469-10
- Oxaliplatin injection, Mylan (Viatris), 5 mg/mL, 20 mL vial, 1 count, NDC 67457-0442-20
- Oxaliplatin injection, Pfizer, 5 mg/mL, 10 mL vial, 1 count, NDC 61703-0363-18
- Oxaliplatin injection, Sagent, 5 mg/mL, 20 mL vial, 1 count, NDC 25021-0233-20

Estimated Resupply Dates

- Accord has oxaliplatin 5 mg/mL 10 mL and 20 mL vials on back order and the company cannot estimate a release date.
- Ingenus has oxaliplatin 5 mg/mL 10 mL and 20 mL vials on back order and the company cannot estimate a release date.
- Fresenius Kabi has short-dated oxaliplatin 5 mg/mL 10 mL vials available with an expiration date of < 7 months.
- Pfizer has short-dated oxaliplatin 5 mg/mL 20 mL vials available in limited supply.
- Sagent has short-dated oxaliplatin 5 mg/mL 10 mL vials available with an expiration date of October 2026.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.